全文获取类型
收费全文 | 882151篇 |
免费 | 73023篇 |
国内免费 | 1886篇 |
专业分类
耳鼻咽喉 | 13167篇 |
儿科学 | 25177篇 |
妇产科学 | 25512篇 |
基础医学 | 127172篇 |
口腔科学 | 25824篇 |
临床医学 | 77383篇 |
内科学 | 168673篇 |
皮肤病学 | 17806篇 |
神经病学 | 72281篇 |
特种医学 | 35985篇 |
外国民族医学 | 173篇 |
外科学 | 139380篇 |
综合类 | 24804篇 |
现状与发展 | 2篇 |
一般理论 | 268篇 |
预防医学 | 68355篇 |
眼科学 | 20866篇 |
药学 | 66072篇 |
中国医学 | 1625篇 |
肿瘤学 | 46535篇 |
出版年
2018年 | 7950篇 |
2015年 | 8314篇 |
2014年 | 11677篇 |
2013年 | 17688篇 |
2012年 | 24217篇 |
2011年 | 25383篇 |
2010年 | 14612篇 |
2009年 | 13682篇 |
2008年 | 23741篇 |
2007年 | 25871篇 |
2006年 | 25721篇 |
2005年 | 25312篇 |
2004年 | 24796篇 |
2003年 | 23849篇 |
2002年 | 22901篇 |
2001年 | 36341篇 |
2000年 | 36957篇 |
1999年 | 31379篇 |
1998年 | 9372篇 |
1997年 | 8666篇 |
1996年 | 8566篇 |
1995年 | 8117篇 |
1994年 | 7824篇 |
1992年 | 26865篇 |
1991年 | 26332篇 |
1990年 | 25819篇 |
1989年 | 24872篇 |
1988年 | 23386篇 |
1987年 | 23058篇 |
1986年 | 21892篇 |
1985年 | 21258篇 |
1984年 | 16503篇 |
1983年 | 14113篇 |
1982年 | 8930篇 |
1981年 | 8272篇 |
1980年 | 7724篇 |
1979年 | 16839篇 |
1978年 | 12192篇 |
1977年 | 10258篇 |
1976年 | 9398篇 |
1975年 | 10239篇 |
1974年 | 12736篇 |
1973年 | 12215篇 |
1972年 | 11618篇 |
1971年 | 10768篇 |
1970年 | 10290篇 |
1969年 | 9972篇 |
1968年 | 8964篇 |
1967年 | 8298篇 |
1966年 | 7703篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
61.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
62.
63.
64.
65.
66.
W. Do T. Elzerman R. de Bree A. Rosenberg T. Forouzanfar E.M. Van Cann 《International journal of oral and maxillofacial surgery》2021,50(5):591-597
The aim of this study was to analyse the effect of body mass index (BMI), both low and high values, on the perioperative complication rate in patients with oral squamous cell carcinoma (OSCC). The medical records of 259 patients operated between 2014 and 2017 for OSCC were reviewed. Univariate and multivariate analyses were performed. Sixty of the 259 patients developed 87 complications. Low or high BMI was not associated with the perioperative complication rate. A longer operating time and increased blood loss were associated with a higher perioperative complication rate and higher Clavien–Dindo grade. Low BMI, American Society of Anesthesiologists score 2 and 3, a longer operating time, and increased blood loss were associated with a longer hospital stay. Low BMI was associated with a longer hospital stay. Neither low nor high BMI was associated with the perioperative complication rate. A longer operating time and increased blood loss were associated with a higher perioperative complication rate and higher Clavien–Dindo grade. 相似文献
67.
68.
69.
Erik de Bakker Mirthe A. M. van der Putten Martijn W. Heymans Sander W. Spiekstra Taco Waaijman Liselotte Butzelaar Vera L. Negenborn Vivian K. Beekman Erman O. Akpinar Thomas Rustemeyer Frank B. Niessen Susan Gibbs 《Experimental dermatology》2021,30(1):169-178
Unpredictable hypertrophic scarring (HS) occurs after approximately 35% of all surgical procedures and causes significant physical and psychological complaints. Parallel to the need to understanding the mechanisms underlying HS formation, a prognostic tool is needed. The objective was to determine whether (systemic) immunological differences exist between patients who develop HS and those who develop normotrophic scars (NS) and to assess whether those differences can be used to identify patients prone to developing HS. A prospective cohort study with NS and HS groups in which (a) cytokine release by peripheral blood mononuclear cells (PBMC) and (b) the irritation threshold (IT) after an irritant (sodium lauryl sulphate) patch test was evaluated. Univariate regression analysis of PBMC cytokine secretion showed that low MCP‐1, IL‐8, IL‐18 and IL‐23 levels have a strong correlation with HS (P < .010‐0.004; AUC = 0.790‐0.883). Notably, combinations of two or three cytokines (TNF‐a, MCP‐1 and IL‐23; AUC: 0.942, Nagelkerke R2: 0.727) showed an improved AUC indicating a better correlation with HS than single cytokine analysis. These combination models produce good prognostic results over a broad probability range (sensitivity: 93.8%, specificity 86.7%, accuracy 90,25% between probability 0.3 and 0.7). Furthermore, the HS group had a lower IT than the NS group and an accuracy of 68%. In conclusion, very fundamental immunological differences exist between individuals who develop HS and those who do not, whereas the cytokine assay forms the basis of a predictive prognostic test for HS formation, the less invasive, easily performed irritant skin patch test is more accessible for daily practice. 相似文献
70.